e-Clinical Trial Technologies

Global Market Trajectory & Analytics

MCP-6744

EXECUTIVE ENGAGEMENTS

POOL

2502
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

452
Interactions with Platform & by Email

PARTICIPANTS

73
Unique # Participated

VALIDATIONS

22
Responses Validated*

COMPANIES

85
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

60

PAGES

175

EDITION

15

PRICE

USD 5600

CODE

MCP-6744


COMPETITIVE METRICS

COMPANY

D S N T

% *

Acceliant

Login Required

AG Mednet, Inc.

Login Required

Almac Group

Login Required

Anju ClinPlus LLC

Login Required

Anju Software

Login Required

ArisGlobal LLC

Login Required

Arithmos Srl

Login Required

arivis AG

Login Required

Aurea Software

Login Required

BioClinica

Login Required

SUBMIT
* D = Dominant; S = Strong; N = Niche; T = Trivial
* Validated respondents are incentivized with cluster data
Note: Best viewed in Landscape Mode
VIEW ENTIRE POOL OF 85 COMPETITORS

Login to access data silos

  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for e-Clinical Trial Technologies estimated at US$5.4 Billion in the year 2020, is projected to reach a revised size of US$9.9 Billion by 2027, growing at a CAGR of 8.9% over the analysis period 2020-2027. EDC, one of the segments analyzed in the report, is projected to record a 8.8% CAGR and reach US$4.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the RTSM segment is readjusted to a revised 8.1% CAGR for the next 7-year period.
The e-Clinical Trial Technologies market in the U.S. is estimated at US$1.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2027 trailing a CAGR of 8.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.2% and 7.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.3% CAGR.
In the global CTMS segment, USA, Canada, Japan, China and Europe will drive the 10.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$971 Million in the year 2020 will reach a projected size of US$2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.1 Billion by the year 2027.

SELECT PLAYERS

BioClinica; Bio-Optronics; CRF Health; Datatrak International; e-Clinical solutions Inc.; ERT; MaxisIT; Medidata Solutions; OmniComm Systems; Oracle Corporation; PAREXEL International Corporation

SEGMENTS

» Application (EDC, RTSM, CTMS, ePROs)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
A Prelude
Cost-Containment: An Important Factor Increasing the Uptake of e-Clinical Trial Technologies
Global Market Overview
Outsourcing of Clinical Studies to Developing Countries Benefits Market
Globalization Boosts e-Clinical Trials Market
Key Challenges for e-Clinical Trials
Role of Contract Research Organizations (CROs) in Clinical Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Surging Global Population Offers Increased Growth Opportunities
Pharmaceutical Firms and CROs to Drive Adoption Rate
Rise in Clinical Trial Complexities Propels e-Clinical Trial Technologies Demand
CROs - The Targeted Customers for e-Clinical Trial Technologies
Increased Importance of e-Clinical Integration
Big Data and Patient Centricity: Areas to Increase Focus Upon
Esource Documentation Witnesses Increased Traction
Increased Adoption of electronic Trial Master File (eTMFs)
Risk-Based Monitoring Witnesses New Modifications
Growing Implementation of e-Consent
Increased Investments in Virtual Clinical Trials
Open Source - Emerging Solutions in Clinical Trials Domain
Mobile Technologies to Help Trial Operators in Tackling Challenges
Smartphones & Tablets: The New Age ePRO Devices
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for e-Clinical Trial Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for e-Clinical Trial Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for e-Clinical Trial Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for EDC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for EDC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for EDC by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for RTSM by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for RTSM by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for RTSM by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for CTMS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for ePROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for ePROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for ePROs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for e-Clinical Trial Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for e-Clinical Trial Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for e-Clinical Trial Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2012, 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2012, 2020 & 2027
Total Companies Profiled: 85

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com